The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III

Authors:

Stevenson MD, Macdonald FC, Langley J, Hunsche E and Akehurst R.

Publication Type:

Journal Article

Publication Name:

Value Health

Citation:

Stevenson MD, Macdonald FC, Langley J, Hunsche E and Akehurst R. The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III. Value Health. 2009;12(8):1100-5.

 


Link to publication ⟶

⟵ Back to Search Results